Keros Therapeutics Inc
NASDAQ:KROS

Watchlist Manager
Keros Therapeutics Inc Logo
Keros Therapeutics Inc
NASDAQ:KROS
Watchlist
Price: 21.53 USD 1.41%
Market Cap: 656m USD

Intrinsic Value

The intrinsic value of one KROS stock under the Base Case scenario is 1.54 USD. Compared to the current market price of 21.53 USD, Keros Therapeutics Inc is Overvalued by 93%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

KROS Intrinsic Value
1.54 USD
Overvaluation 93%
Intrinsic Value
Price
Base Case Scenario

Valuation History
Keros Therapeutics Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about KROS?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is KROS valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Keros Therapeutics Inc.

Explain Valuation
Compare KROS to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about KROS?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Keros Therapeutics Inc

Current Assets 719.3m
Cash & Short-Term Investments 693.5m
Receivables 3.5m
Other Current Assets 22.3m
Non-Current Assets 23.5m
PP&E 22m
Other Non-Current Assets 1.4m
Current Liabilities 24.1m
Accounts Payable 2.3m
Accrued Liabilities 17.3m
Other Current Liabilities 4.5m
Non-Current Liabilities 15.1m
Other Non-Current Liabilities 15.1m
Efficiency

Free Cash Flow Analysis
Keros Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Keros Therapeutics Inc

Revenue
246.7m USD
Operating Expenses
-203.1m USD
Operating Income
43.6m USD
Other Expenses
20.9m USD
Net Income
64.4m USD
Fundamental Scores

KROS Profitability Score
Profitability Due Diligence

Keros Therapeutics Inc's profitability score is 45/100. The higher the profitability score, the more profitable the company is.

45/100
Profitability
Score

Keros Therapeutics Inc's profitability score is 45/100. The higher the profitability score, the more profitable the company is.

KROS Solvency Score
Solvency Due Diligence

Keros Therapeutics Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
81/100
Solvency
Score

Keros Therapeutics Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

KROS Price Targets Summary
Keros Therapeutics Inc

Wall Street analysts forecast KROS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for KROS is 23.84 USD with a low forecast of 16.16 USD and a high forecast of 36.75 USD.

Lowest
Price Target
16.16 USD
25% Downside
Average
Price Target
23.84 USD
11% Upside
Highest
Price Target
36.75 USD
71% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Keros Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for KROS is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

KROS Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one KROS stock?

The intrinsic value of one KROS stock under the Base Case scenario is 1.54 USD.

Is KROS stock undervalued or overvalued?

Compared to the current market price of 21.53 USD, Keros Therapeutics Inc is Overvalued by 93%.

Back to Top